Labixiaoxin Snacks Group Ltd. (1262) AI Stock Analysis

• Market Cap: HK$439.02M
• Dividend Yield: N/A
• Average Volume (3M): 39.44K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.12
• Revenue Growth: 10.98%
• EPS Growth: 29.31%
• Country: HK
• Employees: 860
• Sector: Consumer Defensive
• Sector Strength: 53
• Industry: Packaged Foods
• EPS (TTM): -0.25
• Shares Outstanding: 218,416,090
• 10 Day Avg. Volume: 3,460
• 30 Day Avg. Volume: 39,440
• PEG Ratio: -0.08
• Price to Book (P/B): 1.76
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -19.42
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 51 Neutral
• Price Target: HK$2.00 ▼(-0.50%Downside)

The primary concern for Labixiaoxin Snacks Group Ltd. is its financial performance, marked by high leverage and operational inefficiencies, resulting in a low score. Technical analysis provides some optimism with potential upward momentum, but valuation concerns persist due to negative profitability and no dividend yield. Overall, the stock's risks outweigh its current technical strengths.

Labixiaoxin Snacks Group Ltd. Business Overview & Revenue Model

Company Description

Labixiaoxin Snacks Group Ltd. (1262) is a prominent company in the food and beverage industry, primarily engaged in the production and distribution of various snack products. The company is renowned for its diverse portfolio of snacks, which includes jelly products, confectioneries, and beverages. Labixiaoxin aims to appeal to a broad consumer base through innovative flavors and high-quality ingredients, ensuring a strong presence in both domestic and international markets.

How the Company Makes Money

Labixiaoxin Snacks Group Ltd. generates revenue primarily through the production and sale of its snack products. The company operates a vertically integrated business model, where it controls the manufacturing, distribution, and marketing of its product lines. Key revenue streams include sales from its core snack categories such as jelly products, candies, and beverages. Additionally, Labixiaoxin leverages strategic partnerships with retailers and distributors to expand its market reach, both in China and abroad. The company's ability to innovate with new product offerings and flavors, along with its strong brand recognition, also plays a critical role in driving sales and maintaining a competitive edge.

Labixiaoxin Snacks Group Ltd. Financial Statement Overview

Summary

Labixiaoxin Snacks Group Ltd. exhibits revenue growth but faces challenges in profitability and cash flow generation. High leverage and declining equity are key risks, while operational inefficiencies further pressure financial stability. Strategic improvements are necessary to enhance financial health.

Income Statement

The company shows some revenue growth with a 13.39% increase from 2023 to 2024, but profitability is a concern given the negative net profit margin of -10.79% for 2024. The gross profit margin is 27.06%, indicating some cost control, but negative EBIT and EBITDA margins suggest operational inefficiencies.

Balance Sheet

The high debt-to-equity ratio of 2.13 in 2024 indicates significant leverage, posing financial stability risks. The equity ratio is 27.02%, showing moderate asset financing by equity, but a declining trend in stockholders' equity suggests weakened financial health.

Cash Flow

The absence of positive operating cash flow and free cash flow in 2024 is concerning, highlighting potential liquidity issues. Previous periods showed improvement in free cash flow, but the lack of data for 2024 prevents a comprehensive analysis.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	866.67M	764.38M	684.26M	648.07M	508.84M
Gross Profit	234.62M	218.94M	244.19M	224.28M	166.54M
EBITDA	-35.72M	-46.04M	658.00K	81.80M	108.73M
Net Income	-93.46M	-104.75M	-75.33M	-65.20M	-29.40M
Balance Sheet
Total Assets	793.84M	810.91M	977.31M	1.29B	1.53B
Cash, Cash Equivalents and Short-Term Investments	52.50M	44.32M	71.88M	80.57M	258.84M
Total Debt	456.40M	451.27M	512.44M	565.59M	690.74M
Total Liabilities	579.32M	588.35M	650.00M	887.41M	1.06B
Stockholders Equity	214.52M	222.56M	327.31M	402.64M	467.84M
Cash Flow
Free Cash Flow	-34.23M	55.42M	-4.98M	-156.86M	-21.57M
Operating Cash Flow	31.53M	88.64M	15.46M	-135.29M	-12.47M
Investing Cash Flow	-65.54M	-32.89M	55.94M	113.42M	300.93M
Financing Cash Flow	42.19M	-83.31M	-80.09M	-156.41M	-54.46M

Labixiaoxin Snacks Group Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.01
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1262, the sentiment is Positive. The current price of 2.01 is below the 20-day moving average (MA) of 2.07, above the 50-day MA of 2.00, and above the 200-day MA of 1.71, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 46.43 is Neutral, neither overbought nor oversold. The STOCH value of 36.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1262.

Labixiaoxin Snacks Group Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1837	79 Outperform	HK$1.73B	8.41	12.91%	7.03%	9.63%	20.08%
2317	77 Outperform	HK$1.02B	8.15	5.39%	16.34%	-1.88%	129.25%
1285	68 Neutral	HK$423.30M	7.17	5.59%	10.65%	4.97%	-16.24%
1583	66 Neutral	HK$1.04B	45.54	1.74%	1.57%	-0.82%	―
1767	65 Neutral	HK$295.00M	7.99	8.18%	2.40%	>-0.01%	16.04%
Sector *	61 Neutral	HK$21.17B	12.34	0.81%	4.52%	2.72%	-47.45%
1262	51 Neutral	HK$439.02M	―	-42.82%	―	10.98%	29.31%

Labixiaoxin Snacks Group Ltd. Corporate Events

Labixiaoxin Snacks Group Ltd. Unanimously Passes AGM Resolutions

Labixiaoxin Snacks Group Ltd. announced that all ordinary resolutions proposed at their Annual General Meeting on June 19, 2025, were passed unanimously. This includes the adoption of financial statements, re-election of directors, and granting a mandate to issue shares, reflecting strong shareholder support and potentially impacting the company’s strategic operations and market positioning positively.

Labixiaoxin Snacks Group Ltd. Updates Nomination Committee Structure

Labixiaoxin Snacks Group Ltd. has revised the terms of reference for its Nomination Committee, emphasizing a structure that includes a majority of independent non-executive directors and gender diversity among its members. This move is aimed at enhancing governance and ensuring diverse perspectives in decision-making, potentially impacting the company’s strategic direction and stakeholder confidence.

Labixiaoxin Snacks Group Ltd. Updates Nomination Committee Composition

Labixiaoxin Snacks Group Ltd. announced a change in the composition of its Nomination Committee, with Ms. Wu Qiongyao replacing Mr. Zheng Yu Shuang as a member, effective June 19, 2025. This change aligns with amendments to the Listing Rules and Corporate Governance Code, aiming to enhance the board’s effectiveness and diversity, thereby improving the company’s corporate governance practices.

Labixiaoxin Snacks Group Ltd. Announces Board Composition and Roles

Labixiaoxin Snacks Group Ltd. has announced the composition of its board of directors, highlighting the roles and functions of each member. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to the audit, nomination, and remuneration committees. This announcement provides clarity on the governance structure, potentially impacting the company’s strategic direction and stakeholder confidence.

Labixiaoxin Snacks Group Ltd. Announces 2025 Annual General Meeting

Labixiaoxin Snacks Group Ltd. has announced its upcoming annual general meeting scheduled for June 19, 2025, in Hong Kong. Key agenda items include the adoption of financial statements for 2024, re-election of directors, and authorization for the board to fix remuneration for directors and auditors. The meeting will also consider resolutions to empower directors to manage share-related activities, which could impact the company’s capital structure and shareholder value.